戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 expression induced RPE cell apoptosis, which was abrogated by 100 nm docosahexaenoic acid, 10 ng/ml p
2                        This repopulation can be abrogated by a PGE2-neutralizing antibody and celecox
3 ic function for a wild-type polyQ tract that is abrogated by a competing longer polyQ mutation in a d
4                        The function of AAGAB is abrogated by a mutation that causes punctate palmopla
5        Interestingly, SMN-Gemin2 interaction is abrogated by a spinal muscular atrophy (SMA)-causing
6 naling was found when GLP-1R internalization was abrogated by a dominant-negative version of dynamin
7                                  This effect was abrogated by a GABAA-R antagonist.
8  mice, secretion of IL5, IL13, IL6 and IL17A was abrogated by a mechanism involving IL33 signaling in
9              Chaperone-mediated dissociation was abrogated by a non-hydrolysable ATP analogue, indica
10 st differentiation in vitro, and this effect was abrogated by a physiological BMP-2 inhibitor, noggin
11 NO synthesis in a dose-dependent manner that was abrogated by a specific miR-939 inhibitor.
12                                      Effects were abrogated by a vascular endothelial growth factor (
13 m binding to Bcl-2/Bcl-xL; the latter effect was abrogated by ABT-737.
14 masome assembly and activation, effects that were abrogated by acetylation mimic-modified SOD2.
15 neously enhancing muscle regeneration, which is abrogated by adaptive transfer of normal macrophages.
16 roved cognition in 5xFAD mice, both of which were abrogated by additional TREM2 knockout.
17 nduction in mice drives lung fibrosis, which is abrogated by administration of anti-CD47.
18 ydroethidium fluorescence, an elevation that was abrogated by administration of nitro-l-arginine meth
19 and interleukin 6 responses to infection and was abrogated by alveolar macrophage depletion, using cl
20                                These effects were abrogated by AMPK silencing.
21                                These effects are abrogated by an intra-arterial infusion of corticost
22 ion of human platelets in vitro, which could be abrogated by an antipodoplanin antibody.
23 Cs/ALDH1(-)CD44(-)-HNC and this effect could be abrogated by an IL-6-neutralizing antibody.
24 and activity in HLA-DR/TLR-transfected cells is abrogated by an anti-HLA-DR Ab.
25                         PMA-induced shedding was abrogated by an ADAM (A disintegrin and metalloprote
26    Analogue potentiation of the GABA current was abrogated by an alpha(1) subunit Q241L mutation, ind
27 ne receptor agonist U46,619, and this effect was abrogated by an antagonist of the DP1 prostanoid rec
28 the immune activation of cardiac fibroblasts was abrogated by an IL-1R antagonist and an IL-1alpha-bl
29 d expression of M2 genes by TonEBP knockdown was abrogated by antagonism of IL-10 by either neutraliz
30 as associated with ICOS/ICOSL engagement and was abrogated by antagonist anti-ICOS and anti-ICOSL ant
31 s, and that virus infectivity in HT-29 cells is abrogated by anti-A-type antibodies as well as signif
32 eptide concentration-dependent manner, which is abrogated by anti-defensin alpha-1 IgG.
33 ration in vitro toward tumor extracts, which was abrogated by anti-CCL2 neutralizing Abs.
34 KO mice and that increased IL-17A expression was abrogated by anti-IL-10 Ab treatment.
35 mmatory cytokine production in a manner that was abrogated by anti-PD-L1 blocking antibody.
36                     The induction of M cells was abrogated by anti-TNF-alpha blockade, suggesting tha
37                              These responses were abrogated by anti-CD4 antibodies and mutagenesis of
38 eased AHR and higher leukotriene levels that were abrogated by anti-PlGF Ab or the 5-lipoxygenase inh
39 late-phase decrease in body temperature that was abrogated by antibody-mediated depletion of neutroph
40  a chemoprotective tumor cell niche that can be abrogated by Axl-targeting approaches.
41 ere similarly induced by LMP-400 and CPT and were abrogated by AZD7762.
42 d activation of the neutrophil NADPH oxidase was abrogated by bacterium-derived proteolysis of galect
43 genic capacity of Th17 cells to transfer EAU was abrogated by BET inhibitors in an adoptive transfer
44 une cytokine elicitation by all Ad serotypes was abrogated by blockade of endosomal acidification, ca
45 wling behavior in CD14(dim)CD16(+) monocytes was abrogated by blockade of ICAM1, VCAM1, or CX3CL1, in
46                                  This effect was abrogated by blockade of TIGIT's complementary costi
47   A component of FIV that is Kir independent is abrogated by blocking Ca(2+) -sensitive K(+) channels
48                      This latter interaction was abrogated by blocking protein kinase C activity, res
49  increased sperm intracellular Ca(2+), which was abrogated by blocking the sperm-specific Ca(2+) chan
50          The antileukemic activity of CB-839 was abrogated by both the expression of a hyperactive GA
51                  These profibrotic responses were abrogated by both genetic and pharmacological disru
52 that MtRS also induces p53 expression, which was abrogated by Ca(2+) chelators and short hairpin RNA-
53 on 2 hr after the intake of CsA, which might be abrogated by calcium channel blockers.
54 ion of beta-catenin critical to osteogenesis were abrogated by calreticulin deficiency or NFAT blocka
55 roliferation caused by blue/green could also be abrogated by capsazepine, and by the antioxidant, N-a
56  (5uM) stimulated proliferation, which could be abrogated by capsazepine.
57   This chemoreflex anti-inflammatory network was abrogated by carotid chemoreceptor denervation and b
58  prevented by stop codons or activity of D10 was abrogated by catalytic site mutations, without other
59 h this epitope suppressed ongoing EAE, which was abrogated by CD8(+) T cell depletion.
60 tional proinflammatory functions in NTN that were abrogated by cell-specific deletion of RORgammat.
61 nhibit translation, and that this activation is abrogated by certain modifications present in cellula
62 man villous trophoblasts, and this induction was abrogated by CH223191, an aryl hydrocarbon receptor
63 gy-initiation proteins Atg3 and Atg5, and it is abrogated by chelating cytoplasmic calcium or inhibit
64                  IL-34 binding to U251 cells was abrogated by chondroitinase ABC treatment, and CS co
65 ibitory effects of PRH on cell proliferation are abrogated by CK2 and that CK2 inhibits the binding o
66 mulation, whereas proliferation of non-Tregs is abrogated by CN inhibitors.
67 ese detrimental effects of diabetes mellitus were abrogated by co-administration of SEP and L-Cit.
68 lasma glucagon concentrations; these effects were abrogated by coinfusion of corticosterone.
69 naling and stroma-mediated resistance, which is abrogated by combination therapy with gamma secretase
70 y responses against pathogenic organisms can be abrogated by commensals; however, the molecular mecha
71 idney allograft rejection phenotype that can be abrogated by complement inhibition.
72  protection against Brucella melitensis that is abrogated by cotransfer of B cells.
73 ortantly, the antimicrobial effect of MSC EV was abrogated by cotreatment with a LTB(4) BLT1 antagoni
74 mide- and IMiD-induced SALL4 degradation can be abrogated by CRBN V388I mutation or SALL4 G416A mutat
75 te growth promotion and myelin disinhibition were abrogated by CRMP2 inhibition and largely mimicked
76 rophic-like disease in STIM1 transgenic mice was abrogated by crossing in a transgene expressing a do
77 -3) The rescue of N57A by G94D in HIV-1(LAI) is abrogated by CsA treatment in some cell types, demons
78  ex vivo osteoblast cultures, an effect that was abrogated by Cthrc1 knockdown.
79 w effects were CXCR4-dependent, because they were abrogated by CXCR4 inhibition.
80                             This interaction is abrogated by cyclin A-CDK2-mediated phosphorylation o
81                                These effects are abrogated by DDX58 knockdown.
82              In addition, maturation of OCLs was abrogated by defective cell fusion of pre-OCLs deple
83 tion of E-Cadherin and upregulation of Snail were abrogated by deguelin treatment.
84                PMA-induced shedding of Tim-3 was abrogated by deletion of amino acids Glu(181)-Asp(19
85 , independent of IL-1beta stimulation, which was abrogated by deletion of IRAK4.
86 ibitor aphidicolin, and active demethylation was abrogated by deletion of Tet3 in both pronuclei.
87 he later phase (and development of fibrosis) was abrogated by deletion of TNFR1.
88 ggesting a role in tumor growth; this effect was abrogated by deletion of two hydrophilic domains.
89 APP, reducing amyloid-beta production, which are abrogated by delta-secretase cleavage of TrkB in AD.
90 -type S. aureus compared with a lukED mutant was abrogated by depleting neutrophils.
91 as confined to the splenic marginal zone and was abrogated by depletion of CD169(+) cells.
92 The antitumor activity from Mertk inhibition was abrogated by depletion of cytotoxic CD8alpha T cells
93                           This amplification was abrogated by depletion of donor CD4 T cells.
94  responsive, whereas their enduring activity is abrogated by different microenvironmental immunosuppr
95 imicrobial peptide human beta-defensin 2 and is abrogated by digestion of milk HA with a specific hya
96 urable endothelial cell NO production, which was abrogated by dihydrotestosterone in an androgen rece
97              Suppression of CGG RNA toxicity was abrogated by disease-associated mutations in TDP-43.
98 n be opposed by HDAC1, but not by HDAC3, and is abrogated by disrupting HIF1alpha-p300 interaction.
99 the in vivo pro-tumorigenic effect of CA-MSC is abrogated by dual blockade with the JAK2 inhibitor ru
100 ER stress observed in hLrp1(-/-) hepatocytes were abrogated by E64D treatment, whereas inhibiting ER
101  confers resistance to bile salts, which can be abrogated by efflux pump inhibitors.
102 ctivated T cells (NFAT) nuclear accumulation was abrogated by either antioxidant supplementation or C
103                             These activities were abrogated by either knocking down PIG3 or mutating
104 f NMC cells induced by knockdown of BRD4-NUT is abrogated by enforced expression of MYC.
105 lls was mediated by complex-type glycans and was abrogated by enzymatic inhibition of N-linked glycos
106                 This constitutive activation was abrogated by ex vivo treatment with the janus kinase
107                             Since the defect is abrogated by exogenous intrarenal cGMP, the renal cGM
108         Vgamma9Vdelta2 T-cell activation can be abrogated by exposing susceptible cells (tumor and my
109                       The actions of miR-10b were abrogated by expressing a modified TIP30 cDNA resis
110  This effect of Asef2 on spines and synapses is abrogated by expression of GEF activity-deficient Ase
111 er was activated by E2F1, and the activation was abrogated by expression of SHP and its co-repressor
112                               This shielding was abrogated by fragment N2.
113 wal defect in transplanted recipients, which was abrogated by genetic ablation or pharmacologic inhib
114 lencing-induced increase in LR-MSC migration was abrogated by genetic and pharmacologic targeting of
115             Intracellular antibody signaling was abrogated by genetic deletion of TRIM21 and was rest
116 ariation in microglial synaptic phagocytosis was abrogated by global REV-ERBalpha deletion, which cau
117 ans and mice, and the effect of AKI on FGF23 was abrogated by GPAT inhibition or Lpar1 deletion.
118 ression of microglial BV-2 activation by ASI was abrogated by GR inhibitor, RU486 or GR siRNA.
119 n rats subjected to coronary ligation, which was abrogated by GR-1.
120 (PAF) causes wheal and flare responses which are abrogated by H1-antihistamines giving rise to the hy
121 mino acids 22-27 of H3, and this interaction is abrogated by H3K27 modification.
122 ol induced S-phase accumulation; this effect was abrogated by HDACI coadministration, which suggests
123 eta mRNA upregulation in chicken macrophages was abrogated by heat inactivation or pre-exposure of th
124 nd AZD-2281 both in vitro and in vivo, which was abrogated by HER2 reduction.
125 d insulin sensitivity in obese M4K4 iKO mice was abrogated by high exogenous insulin over the course
126  HeH and recombinant P. falciparum H3 (PfH3) was abrogated by histone-specific antibodies.
127 nto giant unilamellar vesicles, effects that are abrogated by hydrophobic mutations.
128 gressive 4T1 breast cancer cells in mice can be abrogated by inactivation of tumor-evoked regulatory
129 restricts virus replication, and infectivity is abrogated by inactivation (e.g., irradiation, heating
130 e of binding ligands at the active site, and is abrogated by inactivation of the catalytic residue Se
131             However, the increase in EHT can be abrogated by increased Notch signalling.
132  inhibition of B6.K(d) heart graft rejection was abrogated by increasing T cell help through transfer
133 of CM-Plin5 mice or Plin5-transfected cells, is abrogated by incubation with PKA.
134 clusively within RV-infected cells and could be abrogated by inhibiting the lysosomal-endosomal degra
135                                This increase was abrogated by inhibiting inositol trisphosphate-media
136 s and that the efficacy of this strategy can be abrogated by inhibition of TGFbetaR on BM-hMSCs.
137 njury induced sickness behavior, which could be abrogated by inhibition of the HMGB1-RAGE pathway or
138 or HSF1-mediated neuroprotection, protection is abrogated by inhibition of classical histone deacetyl
139 y controlled by hypoxia and how this control is abrogated by inhibition of insulin-like growth factor
140                           This up-regulation is abrogated by inhibition of TGFBR2 kinase activity, sm
141 that this co-culture-induced chemoresistance is abrogated by inhibition of the CXCR4 and hedgehog pat
142 ty in mesenchymal progenitor cells, and this was abrogated by inhibition of ataxia-telangiectasia-mut
143 with CAFs led to increased invasiveness that was abrogated by inhibition of CXCR4.
144 3beta (GSK-3beta) at serine 9, as the latter was abrogated by inhibition of either PI3K or Akt.
145   When the Grp94-mutant myocilin interaction is abrogated by inhibitors or siRNA, mutant myocilin is
146                                This response was abrogated by inhibitors of ASM or in ASM-deficient m
147   Increases in VEGF and NADPH oxidase levels were abrogated by inhibitors of NADPH oxidase and MAPK,
148 ed with expression of TNF receptor TNFR1 and was abrogated by interfering with the TNFalpha/TNFR1 int
149                 These effects of FeTMPyP(5+) were abrogated by intra-RVM naloxone, implicating potent
150 ial hypertension, and this protective effect was abrogated by IP antagonists.
151 bly, this function is unique to Hb alpha and is abrogated by its genetic depletion.
152                                These effects were abrogated by JD5037 or the SPT inhibitor myriocin.
153 4 binding to the BDNF promoter, effects that were abrogated by JQ1 (an inhibitor of BRD4).
154               However, the enhanced activity is abrogated by kinase-dead, dominant negative mutants o
155 ive oxygen species generation and cell death were abrogated by knock down of uncoupling protein 3.
156 ased production of superoxide, both of which were abrogated by knockdown or antibody blockade of SIRP
157  inflammatory actions by activated platelets were abrogated by lack of CD40 on injected platelets.
158  (mepS) were synthetic sick, and the defects were abrogated by lack of l,d-transpeptidases, enzymes c
159                           NADHX accumulation was abrogated by lentiviral transduction of subject cell
160 sed expression of let-7 family miRNAs, which was abrogated by Lin28 knockdown.
161  centriole cohesion and basal foot formation are abrogated by loss of Kif3a.
162 ral endothelial alterations induced by Abeta were abrogated by lovastatin, consistent with its anti-i
163                        Thus, the disease can be abrogated by lowering serum suPAR concentrations thro
164 sed endothelial cell apoptosis, all of which were abrogated by maternal administration of intravenous
165 CPC to isoproterenol-induced cell death that is abrogated by metoprolol.
166 nflammatory molecules and EMMPRIN, and these were abrogated by minocycline.
167  increases lung metastasis in vivo, and this is abrogated by miR-452 overexpression.
168          Left ventricular adverse remodeling was abrogated by MPC therapy, resulting in a marked redu
169                                   The effect is abrogated by mutation of the catalytic Ser-525 and re
170 -loop region in the C-type lectin domain and is abrogated by mutation within the domain.
171 that LpSpl possesses S1P lyase activity that was abrogated by mutation of the catalytic site residues
172 using wild type AChE 3'-UTR RNA segment that was abrogated by mutation of the consensus recognition s
173 ct did not depend on enzymatic activity, but was abrogated by mutations disrupting the hexameric stru
174 tion of high glucose-induced NOX4 expression was abrogated by N(omega)-nitro-l-arginine methyl ester,
175  SERINC5 on antibody-dependent virus capture was abrogated by Nef expression.
176                                These effects were abrogated by NET inhibition with DNAse or a neutrop
177                                This activity was abrogated by neutralization of IL-1beta.
178 uced virus replication in PAR2ko fibroblasts was abrogated by neutralizing IFNbeta antibody.
179 n of metabolic disorders via brain ER stress was abrogated by NF-kappaB inhibition in the hypothalamu
180 r combination induced heart block that could be abrogated by nicotinic receptor blockade.
181 e chemoattractant receptor for chemerin, and was abrogated by NK cell depletion.
182 igation induced STAT5 phosphorylation, which was abrogated by nontoxic concentrations of the JAK1/2 i
183  Furthermore, neuroendocrine gene expression was abrogated by Notch activity in SCLC cells.
184  Notch1 trafficking and signaling in ECs and was abrogated by Notch1 deletion in ECs in vivo.
185                                         This was abrogated by NOX4 small interfering RNA knockdown an
186 HNE-induced increases in GSH and NQO1 levels were abrogated by Nrf2 small interfering RNA in normal c
187 mented AHR to MCh in the OVA/OVA mice, which was abrogated by NVP-QAB-205.
188 persensitive to amino acid feeding, and this is abrogated by oral administration of EGCG prior to cha
189  while in the remaining cases, TP53 activity is abrogated by other oncogenic events, such as hyperact
190 weeks, and endogenous sex hormone production was abrogated by ovariectomy.
191           Inhibitory functions of such uORFs were abrogated by overexpression of complementary tRNA.
192 giotensin-II-promoted MARCKS phosphorylation is abrogated by PEG-catalase, implicating endogenous H(2
193 l of organ transplantation with CD40Ig could be abrogated by permanent depletion of CD8(+) cells that
194 led that the biological effects of MND could be abrogated by pertussis toxin.
195  lysosomal damage and cytotoxicity of Dp44mT were abrogated by Pgp inhibitors, Pgp silencing, or incr
196                                 This process was abrogated by pharmacologic inhibition of PI3Kbeta, b
197 thelial de-differentiation observed in vitro was abrogated by pharmacological blockade of the ALK-5 c
198 ingly, ABHD5-dependent suppression of mTORC1 was abrogated by pharmacological inhibition of DGAT1 or
199                        This mitogenic effect was abrogated by pharmacological inhibition of type I TG
200 spiration and ATP production, an effect that was abrogated by phosphocreatine-mediated reactivation o
201  line expressing endogenous mutated p53, can be abrogated by pre-miR-205 or silencing of mutated p53.
202 lated induction of miR146a and miR155, which is abrogated by pre-treatment with triclosan.
203 lter responses to AMPA receptor agonists and was abrogated by preabsorption of CSF with HEK cells exp
204 en-induced acute liver failure plasma, which was abrogated by preincubation with deoxyribonuclease-I.
205 e oxygen species (ROS) generation because it is abrogated by pretreatment of PC cells with the free r
206 r, FXIIa stimulated IPF HLF migration, which was abrogated by pretreatment of cells with heparinase I
207 MOG-induced models of EAE, respectively, and was abrogated by pretreatment with a depleting anti-CD25
208 induced BBB disruption and neuroinflammation were abrogated by pretreatment with the rho kinase inhib
209                  Moreover, NK-cell expansion was abrogated by prior injection of clodronate-loaded li
210 onversion was reversible by antioxidants and was abrogated by prior methylation of basic amino acids.
211 border assembly induced by Arp2/3 inhibition was abrogated by profilin-1 knockdown.
212 n of miR-31 repressed Fzd9 expression, which was abrogated by prostacyclin.
213 d transendothelial migration capacity, which was abrogated by RAC inhibition.
214 s RANK and undergo hyperproliferation, which is abrogated by RANKL neutralization.
215                            This effect could be abrogated by rapamycin suggesting that mTOR signaling
216                        Ancestry associations were abrogated by recruitment site but not region of ori
217 astasis whose elaboration and tissue effects are abrogated by RLH innate immune responses.
218       Conversely, actin severing by Gelsolin was abrogated by RNA interference-mediated silencing of
219        The relaxin-like actions of CGEN25009 were abrogated by RXFP1 silencing in vitro, and, in comp
220 ation of nPKCs (PKCepsilon) and PKD that can be abrogated by selective inhibitors or by expression of
221      The adverse immunostimulatory responses were abrogated by selective B cell-targeted delivery and
222 show that fusion of macropinosomes/endosomes is abrogated by septin immunodepletion and function-bloc
223     S100P elevation under hypoxic conditions was abrogated by silencing of Cav1 or NF-kappaB function
224 ar signal-related kinase 1/2 and Snail1 that was abrogated by silencing of TrkA or CCN2 using small i
225  CCL5 Such infiltration and tumor regression were abrogated by silencing CCL5 in BECN1-defective tumo
226 uced neurite-like projections, both of which were abrogated by silencing EWS-WT1.
227 nvasion, and the enhancement of invasiveness was abrogated by small interfering RNA (siRNA)-mediated
228                              These reactions were abrogated by SNP.
229 ll without any loss of specificity, as entry was abrogated by soluble ephrinB2.
230 tion termination within the rplM 5' UTR that is abrogated by SrmB.
231 levels were maintained, whereas IL-13 levels were abrogated by steroid treatment in neonatal HDM-expo
232 g PD-1 ligand (CD274), and these differences were abrogated by sustained CD274 blockade.
233 ion of NK1-expressing PC, with these effects being abrogated by systemic administration of the opioid
234 and that the aberrant cellular changes could be abrogated by targeting the cell-mechanosensing machin
235  transcription and protein expression, which were abrogated by Tat heat inactivation, immunodepletion
236 igher binding affinity towards H3K36me2 that is abrogated by TBRS-derived missense mutations.
237                                These effects are abrogated by the addition of MAB228 (a monoclonal an
238                       The inhibitory effects are abrogated by the introduction of a function-blocking
239 -) dams provoked pregnancy loss, which could be abrogated by the adoptive transfer of IL-10(+/+) NK c
240                This essential function could be abrogated by the dominant-negative effect of HOXD10 a
241  change in the nuclear morphology and cannot be abrogated by the morphological cues.
242                      Mediator production can be abrogated by the use of inhibitors directed against k
243 tion of AhR is 5-HT(2B) dependent because it is abrogated by the 5-HT(2B)-specific antagonist SB20474
244      In Ewing sarcoma cells, NOTCH signaling is abrogated by the driver oncogene EWS-FLI1.
245 prognostic impact of chemotherapy resistance is abrogated by the implementation of early response-bas
246                 However, the tumor phenotype is abrogated by the introduction of a hypomorphic mutant
247 the angiogenic receptor neuropilin-1 (NRP-1) is abrogated by the liver kinase B1 (LKB1), a serine-thr
248                 This tumor suppressor effect is abrogated by the PC-associated SPOP mutations.
249 poI-induced contact between homologous genes is abrogated by the transcriptional inhibitors actinomyc
250 nd to lower concentrations of eotaxin, which was abrogated by the above-mentioned PKCbetaII inhibitor
251 ; and queuine-stimulated in vivo methylation was abrogated by the absence of the enzyme that inserts
252 omprised of Th1, Th17, and Th22 cells, which was abrogated by the addition of anakinra.
253                       This increase in SIRT1 was abrogated by the addition of exogenous pyruvate.
254 ssing the couAB promoter region, and binding was abrogated by the addition of nanomolar quantities of
255                            Furthermore, this was abrogated by the addition of recombinant OA to cultu
256          The toxicity of IL-36beta + TT/Alum was abrogated by the administration of a neutralizing an
257 f S100A9KO mice, but not wild-type mice, and was abrogated by the administration of anti-CD8 Ab or ad
258 ile recruitment to the oxidative DNA lesions was abrogated by the anti-oxidant N-acetylcysteine, this
259 HRL-4-mediated degradation of E. chaffeensis was abrogated by the autophagy inhibitor 3-methyladenine
260 gmented by dominant-negative RhoA(T19N), but was abrogated by the constitutive-active RhoA(G14V).
261 uclear localization of P. pastoris MS (PpMS) was abrogated by the deletion of 107 C-terminal amino ac
262 e, the suppressive effect of oxo-m on PF-LTP was abrogated by the GDP analog GDP-beta-S (applied intr
263 ecreased growth in the presence of Cu, which was abrogated by the introduction of mntA::Tn.
264 in response to interleukin-7, an effect that was abrogated by the JAK1/2 inhibitor ruxolitinib.
265 nced KLF6-mediated growth suppression, which was abrogated by the KLF6-4A phosphomutant.
266                               The inhibition was abrogated by the LOXL2 function-blocking monoclonal
267         Induction of Gadd45-beta by LY379268 was abrogated by the mGlu2/3 receptor antagonist (2S)-2-
268 ulin autoantibodies by TRAV5D-4 alpha-chains was abrogated by the mutation of insulin peptide B:9-23
269                                  This effect was abrogated by the PDGFRalpha-specific inhibitor creno
270 ated KLF6 degradation in the presence of SV1 was abrogated by the proteasome inhibitor MG132.
271 s revealed that TNF-alpha-induced cell death was abrogated by the simultaneous inhibition of caspases
272 ypt organoid proliferation and crypt budding was abrogated by the Wnt inhibitor IWP2.
273 Ancestry-related differences in relapse risk were abrogated by the addition of a single extra phase o
274 d STAT3 phosphorylation and astrogliogenesis were abrogated by the addition of neutralizing antibody
275 l of the effects of TNF-alpha on SDC4 and HS were abrogated by the metalloproteinase (MMP) inhibitor
276                       These Ca(2+) increases were abrogated by the MS channel inhibitor Grammostola s
277 s-specific CTLs, and its therapeutic effects were abrogated by the mTOR inhibitor rapamycin.
278  Spontaneous and TGF-beta1-stimulated EndoMT were abrogated by the restoration of functional CAV1 dom
279 y the effect of excretory-secretory products is abrogated by TLR2 antagonist.
280  mice with burn injury and this effect could be abrogated by TNF-alpha or caspase-3 inhibitors.
281 ars independent of RNAP convoy formation and is abrogated by topoisomerase I activity.
282    Thus, TorA-nucleoporin interactions might be abrogated by TorA-DeltaE, suggesting new experimental
283 f colitis, and this increased susceptibility is abrogated by transfusion of HYAL2-competent platelets
284  or high glucose in vitro, and this increase was abrogated by transgenic overexpression of superoxide
285 e single binding sites in vitro, and binding was abrogated by transversions in the binding sites that
286 ta indicate that inflammatory osteolysis can be abrogated by treatment with a molecule composed of th
287 f MAPK inhibitor resistance in melanoma, can be abrogated by treatment with the MDM2 inhibitor Nutlin
288  transcription 5 (STAT5) phosphorylation and is abrogated by treatment with C188-9, a STAT3/5 inhibit
289 mia cells correlated with dCK expression and was abrogated by treatment with a dCK inhibitor.
290                                   Resistance was abrogated by treatment with agents that scavenged RO
291 mice suppressed melanoma growth; this effect was abrogated by treatment with neutralizing antibodies
292 ce by the ERBB2 extracellular domain mutants was abrogated by treatment with small-molecule inhibitor
293                              This resistance was abrogated by treatment with the FGFR tyrosine kinase
294                       The effects of HI diet were abrogated by treatment of the mice with N-acetyl cy
295 ng term barrier-promoting effects of HDL-S1P were abrogated by treatment with the recycling blocker,
296                                 However, VNC was abrogated by TRPV4 channel, GABAB, as well as an ade
297      In all of the mAbs, Fc receptor binding was abrogated by Trx activity, with significant loss in
298                    The effects of mast cells were abrogated by type I transforming growth factor beta
299      To ascertain if this interference could be abrogated by using a synthetic non-acetylated oligosa
300                 All these beneficial effects were abrogated by vagotomy.

 
Page Top